HORIZON PHARMA INVT LTD's ticker is and the CUSIP is 44052TAB7. A total of 34 filers reported holding HORIZON PHARMA INVT LTD in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $71,631,000 | -15.9% | 61,415,000 | -4.1% | 0.10% | +23.1% |
| Q4 2019 | $85,169,000 | +33.9% | 64,015,000 | +17.5% | 0.08% | +23.8% |
| Q3 2019 | $63,626,000 | +13.3% | 54,485,000 | +6.9% | 0.06% | +21.2% |
| Q2 2019 | $56,150,000 | +20.4% | 50,985,000 | +23.5% | 0.05% | +13.0% |
| Q1 2019 | $46,646,000 | -27.0% | 41,280,000 | -36.2% | 0.05% | -34.3% |
| Q4 2018 | $63,896,000 | +15.1% | 64,715,000 | +17.2% | 0.07% | +40.0% |
| Q3 2018 | $55,496,000 | +89.3% | 55,220,000 | +80.8% | 0.05% | +72.4% |
| Q2 2018 | $29,318,000 | +204.3% | 30,540,000 | +195.6% | 0.03% | +222.2% |
| Q1 2018 | $9,633,000 | -0.1% | 10,330,000 | 0.0% | 0.01% | +12.5% |
| Q4 2017 | $9,642,000 | -1.9% | 10,330,000 | -4.6% | 0.01% | -11.1% |
| Q3 2017 | $9,832,000 | +61.0% | 10,830,000 | +53.0% | 0.01% | +50.0% |
| Q2 2017 | $6,107,000 | -6.8% | 7,080,000 | 0.0% | 0.01% | 0.0% |
| Q1 2017 | $6,550,000 | -4.0% | 7,080,000 | 0.0% | 0.01% | 0.0% |
| Q4 2016 | $6,826,000 | -5.4% | 7,080,000 | -4.1% | 0.01% | -14.3% |
| Q3 2016 | $7,214,000 | -73.0% | 7,380,000 | -74.7% | 0.01% | -75.9% |
| Q2 2016 | $26,753,000 | -49.0% | 29,195,000 | -52.9% | 0.03% | -51.7% |
| Q1 2016 | $52,430,000 | – | 61,990,000 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|